Meeting polypoidal choroidal vasculopathy treatment needs halfway

Penny Pooi Wah Lott; Rubamalar  Gunatheesan; Beau  Fenner; Gemmy Chui Ming Cheung

doi:10.35119/myjo.v3i3.247

open access

Abstract viewed - 344 times
PDF downloaded - 359 times

Submitted: 2021-09-27

DOI: 10.35119/myjo.v3i3.247

Editorial

Published: 2021-09-27

Meeting polypoidal choroidal vasculopathy treatment needs halfway

Penny Pooi Wah Lott⁺⁻
Rubamalar Gunatheesan⁺⁻
Beau Fenner⁺⁻
Gemmy Chui Ming Cheung⁺⁻

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Department of Ophthalmology, University of Malaya Eye Research Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Tun Hussein Onn National Eye Hospital, Petaling Jaya, Selangor, Malaysia

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-NUS Graduate Medical School, National University of Singapore, Singapore

anti-VEGF half-dose photodynamic therapy polypoidal choroidal vasculopathy

No abstract available; see PDF for full article